Acupoint Stimulation Improve Postoperative Delirium in Elderly Patients (AICE)

May 25, 2022 updated by: Zhihong LU, Air Force Military Medical University, China

Effect of Transcutaneous Acupoint Electrical Acupoint Stimulation Combined With Auricular Acupressure on Postoperative Delirium in Elderly Patients Undergoing Major Abdominal Surgery: a Pragmatic Randomized Clinical Trial

Postoperative delirium is with increased incidence in elderly patients. Previous studies have shown that acupuncture related techniques could induce protection against brain ischemia and improve outcome after cerebral diseases. In this study the effect of transcutaneous electrical acupoint stimulation combined with auricular acupressure on postoperative delirium will be evaluated.

Study Overview

Detailed Description

Postoperative delirium (POD) is an acute neurological disorder that commonly happens between postoperative days 1 and 3 and more common reported in elderly patients. The rate of delirium differs depending on the patients' characteristics, surgery types and setting of health care. The prevalence of delirium range from 18% to 35 % in a general medical service, and up to half of older patients postoperatively. It has been documented that POD is associated with an increase in mortality and morbidity, increased use of hospital resources, and higher cost of health care. The conventional preventive methods for delirium have focused on minimization or elimination of the predisposing and precipitating factors. Yet, few effective therapies are available for treating POD. New treatments are needed to reduce the prevalence and severity of delirium.

Complementary therapies, particularly acupuncture, have gained increasing attention for their possible value in the prevention and treatment of neurological disorders. Both basic and clinical studies have suggested that acupuncture may be beneficial to postoperative delirium. In functional MRI studies of healthy subjects and nervous system dysfunction patients, acupuncture has been shown to stimulate hippocampus, amygdala and insula, areas of the brain associated with memory, cognition and emotion.

In the clinical, TEAS has been reported to be effective in alleviating delirium in elderly patients with silent lacunar infarction. Evidence also showed that auricular acupunctures are efficacious for preventing postoperative agitation in geriatric patients

Given evidences of the possible efficacy of TEAS and auricular acupressure, we aim to do a 2-arm, randomized, controlled, single-blinded, pragmatic trial to investigate whether transcutaneous electrical acupoint stimulation combined with auricular acupressure is more effective in reducing postoperative delirium in elderly patients than usual care.

Study Type

Interventional

Enrollment (Actual)

210

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shaanxi
      • Xi'an, Shaanxi, China, 710032
        • Xijing Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

61 years to 96 years (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients scheduled for elective abdominal surgery under general anesthesia
  • American Society of Anesthesiologists (ASA) physical status class≤Ⅲ;
  • Mini mental state examination (MMSE) score>20;

Exclusion Criteria:

  • Implantation of a cardiac pacemaker, cardioverter, defibrillator or internal hearing aids;
  • Documented alcohol or substance abuse within 3 months before surgery;
  • Dermatological conditions or frail skin;
  • Dysesthesia or infection over the acupoint stimulation skin area;
  • Limb abnormalities;
  • Allergy to ECG pads;
  • Use of psychoactive medications;
  • Severe visual or auditory impairment;
  • Preoperative history of schizophrenia, epilepsy, parkinsonism, depression, or myasthenia gravis;
  • Brain injury or neurosurgery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
Electrical stimulation will be given 30min before anesthesia and during surgery, auricular acupressure will be given in postoperative 3 days
Bilaterally Hegu (LI4), Neiguan (PC6) and Zusanli (ST36) will be used as the TEAS acupoints. Six acupoints (Shenmen, Point Zero, subcortex, heart, liver, and endocrine) located on ears will be used as the auricular acupressure points.
Sham Comparator: Non-intervention group
Usual care
Patients in this group only receive usual care developed by the study hospital

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of delirium
Time Frame: From the end of surgery to 7 days after surgery
In postoperative 7 days or during patients stay in hospital if discharged within 7 days
From the end of surgery to 7 days after surgery
The severity of delirium
Time Frame: From the end of surgery to 7 days after surgery or during patients stay in hospital if discharged within 7 days
Assessed by memorial delirium assessment scale (MDAS)
From the end of surgery to 7 days after surgery or during patients stay in hospital if discharged within 7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative pain
Time Frame: 24h, 48h, 72h after surgery
Postoperative pain both at rest and with movement using Numeric Rating Scale (NRS)
24h, 48h, 72h after surgery
S100B level
Time Frame: Before surgery and at the end of the surgery
Serum
Before surgery and at the end of the surgery
Neuron-specific enolase level
Time Frame: Before surgery and at the end of the surgery
Serum
Before surgery and at the end of the surgery
Brain-derived neurotrophic factor level
Time Frame: Before surgery and at the end of the surgery
Serum
Before surgery and at the end of the surgery
Tumor necrosis factor-α level
Time Frame: Before surgery and at the end of the surgery
Serum
Before surgery and at the end of the surgery
Interleukin- 6 level
Time Frame: Before surgery and at the end of the surgery
Serum
Before surgery and at the end of the surgery
Aquaporin-4 level
Time Frame: Before surgery and at the end of the surgery
Serum
Before surgery and at the end of the surgery
Postoperative sleep qualiy
Time Frame: 4 days after surgery
Sleep quality within postoperative 4 days using Pittsburgh sleep quality index (PSQI)
4 days after surgery
Length of stay in hospital after sugery
Time Frame: From the day of suregry to discharge from surgery
Days
From the day of suregry to discharge from surgery
Interleukin-10 level
Time Frame: Before surgery and at the end of the surgery
Serum
Before surgery and at the end of the surgery
Matrix metalloproteinase 9 level
Time Frame: Before surgery and at the end of the surgery
Serum
Before surgery and at the end of the surgery
Tau protain level
Time Frame: Before surgery and at the end of the surgery
Serum
Before surgery and at the end of the surgery
β-Amyloid1-42 level
Time Frame: Before surgery and at the end of the surgery
Serum
Before surgery and at the end of the surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Zhihong Lu, Xijing Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 17, 2019

Primary Completion (Actual)

March 10, 2020

Study Completion (Actual)

April 10, 2020

Study Registration Dates

First Submitted

October 28, 2018

First Submitted That Met QC Criteria

October 29, 2018

First Posted (Actual)

October 31, 2018

Study Record Updates

Last Update Posted (Actual)

May 26, 2022

Last Update Submitted That Met QC Criteria

May 25, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

The data of the study will be available for sharing after publishing, including data of the outcomes

IPD Sharing Time Frame

The data of the study will be available for sharing after publishing on peer-reviewed journals, and will be available for 5 years

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Informed Consent Form (ICF)
  • Clinical Study Report (CSR)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Complications

Clinical Trials on Transcutaneous acupoint electrical acupoint stimulation(TEAS) and auricular acupressure

Subscribe